Tarsus Pharmaceuticals, Inc. Share Price
NASDAQ: TARS | Mid CapTarsus Pharmaceuticals, Inc. Stock Performance
Open $66.06 | Prev. Close $65.23 | Circuit Range N/A |
Day Range $63.79 - $67.78 | Year Range $45.19 - $84.84 | Volume 66,388 |
Average Traded $65.05 |
Tarsus Pharmaceuticals, Inc. Share Price Today
As of 9 August 2026, Tarsus Pharmaceuticals, Inc.'s share price is $64.75. The stock opened at $66.06, compared to its previous close of $65.23. During today's trading session, Tarsus Pharmaceuticals, Inc.'s share price traded between $63.79 and $67.78, with an average price of $65.78. Over the past 52 weeks, the stock has recorded a high of $84.84 and a low of $45.19. In terms of performance, Tarsus Pharmaceuticals, Inc.'s share price has declined by 14.25% over the last six months and is up 10.65% on a year-on-year basis.
Tarsus Pharmaceuticals, Inc. Share Price Chart
Tarsus Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators
Market Cap $2.71B | PE Ratio (TTM) -40.72 | Dividend Yield N/A |
EPS (TTM) $-1.59 | Revenue (TTM) $451.36M | Return On Equity (TTM) -19.34% |
Profit Margin -14.72% | Debt to Equity 0.40 | Quarterly Earnings Growth YoY 46.26% |
Tarsus Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Tarsus Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc., a commercial stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for eye care in the United States. The company's lead product candidate is XDEMVY, a novel therapeutic for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. It is also developing TP-04 for the treatment of Ocular Rosacea; TP-05 for potential Lyme disease prophylaxis; and community malaria reduction. In addition, the company develops lotilaner active pharmaceutical ingredient (API) to address diseases in human medicine, including eye care and infectious disease prevention. Tarsus Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in Irvine, California.
Tarsus Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $60.15 | $64.79 | +9.88% |
Jul 2026 | $65.04 | $58.97 | -6.18% |
Jun 2026 | $59.26 | $62.85 | +5.92% |
May 2026 | $62.60 | $59.34 | -6.84% |
Apr 2026 | $70.71 | $63.70 | -9.09% |
Mar 2026 | $74.11 | $70.07 | -7.20% |
Feb 2026 | $65.19 | $75.51 | +16.98% |
Jan 2026 | $81.56 | $64.55 | -21.29% |
Dec 2025 | $80.00 | $82.02 | +2.24% |
Nov 2025 | $69.25 | $80.22 | +16.41% |
Oct 2025 | $58.95 | $68.91 | +15.87% |
Sep 2025 | $58.25 | $59.47 | +1.62% |
TARS Share Price FAQs
What is Tarsus Pharmaceuticals, Inc. share price today?
What is the 52 week high and 52 week low of Tarsus Pharmaceuticals, Inc. stock?
What is TARS's market capitalisation today?
What is TARS's net income for the last quarter?
What is the 5 year returns of TARS?
What is the high & low stock price of TARS today?
Can I buy TARS shares in India?